Axsome Therapeutics (AXSM) Amortization - Intangibles (2022 - 2026)

Axsome Therapeutics (AXSM) has 5 years of Amortization - Intangibles data on file, last reported at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Amortization - Intangibles changed 0.0% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $6.4 million (changed 0.0% YoY), and the FY2025 full-year result was $6.4 million, changed 0.27% from the prior year.
• Amortization - Intangibles slipped to $1.6 million in Q1 2026, from $1.6 million in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $1.6 million in Q3 2022 to a low of $926000.0 in Q2 2022.
• A 5-year average of $1.6 million and a median of $1.6 million in 2024 frame the typical range for Amortization - Intangibles.
• Across the five-year window, Amortization - Intangibles surged 71.6% in 2023 and declined 1.07% in 2025, its largest moves.
• Tracing AXSM's Amortization - Intangibles over 5 years: stood at $1.6 million in 2022, then changed by 0.0% to $1.6 million in 2023, then changed by 0.0% to $1.6 million in 2024, then changed by 0.0% to $1.6 million in 2025, then declined by 2.18% to $1.6 million in 2026.
• Business Quant data shows AXSM's Amortization - Intangibles at $1.6 million in Q1 2026, $1.6 million in Q4 2025, and $1.6 million in Q3 2025.